Cure TV

Sharon L. Bober, director, Sexual Health Program, Dana-Farber Cancer Institute, discusses changes in sexual health as they relate to different treatments for cancer.

There are several agents available for patients who experience recurrence, Kumar says, though nearly all of them have the potential to move to an earlier setting.

Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.

Marianne Davies, from Smilow Cancer Hospital, Yale School of Nursing, provides an overview of immunotherapy-related side effects that patient with lung cancer may experience.

There are many clinical trial opportunities, Tolaney says, before surgery.

Finn says it's important for advocacy organizations to attend and socialize at these conferences to explore possible collaborations.

Jacquelyn Powers, genetic counselor, Abramson Cancer Center, University of Pennsylvania, discusses how to empower patients with information regarding genetic testing.

Jacquelyn Powers, genetic counselor, Abramson Cancer Center, University of Pennsylvania, discusses when individuals should consider genetic testing.

Gregory J. Riely, associate attending physician, Memorial Sloan Kettering Cancer Center, discusses identifying and treating patients with MET exon 14 skipping mutations in lung cancer.

Kim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the importance of meeting other cancer survivors.

Kim Statham Ringen, DVM DACVIM (Oncology), a CURE contributor who is currently surviving stage 4 non-small cell lung cancer, discusses the stigma of lung cancer.

Debra Patt from Texas Oncology and The US Oncology Network discusses some challenges patients face when trying to enroll in the Health Insurance Marketplace.

Debra Patt, from Texas Oncology and The US Oncology Network, discusses the impact of health care reform on patients with cancer.

Fred R. Hirsch, from the University of Colorado and IASLC, discusses some of the unique challenges he faced as a patient.

Bonnie J. Addario discusses the background of the "Genomics of Young Lung Cancer" study.

Susan Krigel, from the Midwest Cancer Alliance, discusses the effect of fear of recurrence on a cancer survivor's quality of life.

Susan Krigel, from the Midwest Cancer Alliance, discusses fear of recurrence among cancer survivors.

Michelle Esser, program manager for research and advocacy, Young Survival Coalition, discusses two encouraging studies presented during the 2015 annual meeting of the American Society of Clinical Oncology (ASCO).

Anjee Davis, president, Fight Colorectal Cancer, discusses the future of research in colorectal cancer and the importance of research advocates.

Jill Stopfer, from the University of Pennsylvania, provides an overview of some limitations of multigene panel testing.

Jill Stopfer, from the University of Pennsylvania, discusses the benefits of multigene panel testing.

Breast surgeon Jessica Ryan discusses recovery from an extreme oncoplasty.

Breast surgeon Jessica Ryan provides an overview of extreme oncoplasty.

Susan Thornton provides an overview of the unmet needs in cutaneous lymphoma.

Susan Thornton discusses her story and her efforts to bridge the knowledge gap between researchers and patients.

Gwendolyn P. Quinn, member, Moffitt Cancer Center, comments on the need to educate all health care providers — especially those caring for patients with cancer — on sexual and reproductive health.

Gwendolyn P. Quinn, member, Moffitt Cancer Center, discusses causes and effects of infertility among survivors of adolescent and young adults cancers.

D. Ross Camidge, director, Thoracic Oncology Clinical Program, University of Colorado Cancer Center, discusses the need for more research into brain metastases in lung cancer patients.